all

The National Lipid Association (NLA) is pleased to announce that the Journal of Clinical Lipidology (JCL), the Association’s official peer-reviewed journal, has achieved an Impact Factor of 6.9 in the 2025 Journal Citation Reports™ (Clarivate), representing a substantial increase from 4.9 in 2024.

The 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia released today, focused on addressing evaluation, management, and monitoring of individuals living with dyslipidemia, including high blood cholesterol, elevated triglycerides, and elevated lipoprotein(a) [Lp(a)].

The National Lipid Association (NLA) today announced the publication of a new meta-analysis evaluating the impact of low-density lipoprotein cholesterol (LDL-C) lowering on major adverse cardiovascular events (MACE) in primary prevention populations. The study synthesizes data from randomized trials of both statin and non-statin therapies and updates a landmark 2012 analysis conducted by the Cholesterol Treatment Trialists’ Collaboration (CTTC).